8 Ibogaine Podcasts

Curated by Ahaan Ugale · Last reviewed Apr 29, 2026

In April 2026, the Trump administration issued an executive order accelerating ibogaine research for veterans, following sustained public advocacy from Joe Rogan, former Texas governor Rick Perry, and attorney Bryan Hubbard, alongside Texas's pledge of $100 million for a new Ibogaine Initiative. Ibogaine remains Schedule I in the United States and carries documented cardiac risks, so most clinical work happens outside U.S. borders, and most lived-experience accounts come from veterans and physicians who have travelled abroad. The eight long-form interviews below pull together that news cycle, the clinical perspective from Stanford's Anna Lembke and Nolan Williams, the Mexican-clinic operator running the Mission Within program for special operators, and the personal accounts of Tier 1 SEALs DJ Shipley and Shawn Ryan. These are interviews and discussions, not medical advice.

Start here for the news cycle around the April 2026 Trump executive order. Rick Perry and Bryan Hubbard walk Joe Rogan through Texas's $100 million Ibogaine Initiative, plans for a unified FDA drug-development trial, and the multi-state legislative strategy via ALEC. Their addiction-interruption and neuroregeneration claims, with references to Stanford imaging work, are advocacy framing, not regulatory consensus.

Texas Ibogaine Initiative funding and legislative campaignIbogaine basics: origin, Bwiti use, non-recreational profileAddiction interruption claims (48–72 hours; two-dose outcomes)PTSD/TBI and neuroregeneration claims; Stanford imaging referencesState-by-state rollout and model legislation via ALEC

The earlier interview that set the campaign in motion. Perry recounts his 17-year evolution from anti-drug Texas governor to ibogaine advocate after seeing combat-injured veterans like Marcus Luttrell, while Hubbard details the Kentucky Ibogaine Initiative's Stanford Nature Medicine study, its political shutdown, and the strategic pivot to Texas. This is the origin story for the news in #2477.

Rick Perry’s evolution from anti-drug conservative to ibogaine advocateVeterans’ mental health crisis: PTSD, TBI, addiction, and systemic government failureIbogaine’s medical profile: mechanism, efficacy, risks, and cardiac safety requirementsStanford Nature Medicine study on ibogaine’s neuroregenerative effects in veteransThe Kentucky Ibogaine Initiative: design, hearings, political shutdown, and fallout
3How to Make Yourself Unbreakable | DJ Shipley

How to Make Yourself Unbreakable | DJ Shipley

Huberman Lab3h 42mOct 6, 2025

Guests: DJ Shipley, Guest 2

The most detailed personal account on the page. Retired Tier 1 Navy SEAL DJ Shipley walks Andrew Huberman through the suicidal darkest-hour decision to try ibogaine and 5-MeO-DMT and what shifted afterward, including how he thinks about empathy, anger, and ego dissolution. Multiple chapters on ibogaine specifically, including 'Medical Ibogaine, Anger, Numbing Out & Hate.' One person's account, not an evidence base.

Daily structure, micro wins, and environmental control for mental healthRole transitions: self, work, and family as separate ‘dials’ not switchesPhysical training as foundation for mental resilience and body awarenessCombat trauma, survivor’s guilt, and the culture of elite special operationsCatastrophic injury, rehab, and the role of elite coaching (Vernon Griffith)

The cautious clinical voice on the page. Stanford addiction psychiatrist Dr. Anna Lembke walks through dopamine-deficit theory, why she is skeptical of psychedelic 'quick fixes' for addiction, and where ibogaine fits — or doesn't — alongside ayahuasca, psilocybin, and MDMA in clinical applications. A useful counter-balance to the lived-experience accounts elsewhere on the page.

Dopamine neurobiology: tonic vs phasic release, pleasure–pain balanceAddiction as a unified brain process across substances and behaviorsDopamine deficit state, anhedonia, and the 30‑day abstinence “reset”Temperament, impulsivity, boredom, modern life and addiction riskRecovery tools: truth-telling, community (12‑step), daily structure, service

Stanford's Dr. Nolan Williams on the brain-circuit evidence base for psychedelic-assisted therapies, including a dedicated chapter on ibogaine and 'Life Review' in PTSD and depression clinical trials. Williams also runs the SAINT/SNT TMS protocol, so this is the clearest treatment of how ibogaine sits next to non-drug interventions for treatment-resistant depression.

Neural circuitry of depression and brain–heart interactionsTranscranial magnetic stimulation (TMS) and the SAINT/SNT protocolPsychedelic‑assisted therapies: ketamine, psilocybin, MDMA, ibogaine, ayahuascaSSRIs, serotonin hypotheses, and the shift to circuit‑based psychiatryTrauma, PTSD, moral injury, and treatment in special operations veterans
6How Do Psychedelics Treat PTSD? - Dr Martin Polanco & Michael Higgs

How Do Psychedelics Treat PTSD? - Dr Martin Polanco & Michael Higgs

Modern Wisdom58mJul 2, 2022

Guests: Michael Higgs, Dr. Martin Polanco

The clinic-operator perspective. Physician Dr. Martin Polanco and former Navy SEAL Michael 'Punky' Higgs explain the Mission Within ibogaine plus 5-MeO-DMT program for active and former special operators in Mexico — how preparation, screening, and integration work, why the program emphasizes that the medicines are catalysts rather than cures, and the legal landscape that pushes most U.S. veterans abroad for treatment.

Culture of emotional suppression and injury underreporting in special operations forcesCumulative impact of trauma, moral injury, and blast-related mild traumatic brain injury (mTBI)Mechanisms and effects of ibogaine and 5-MeO-DMT on PTSD, addiction, and brain healthDesign and process of The Mission Within psychedelic treatment programThe role of preparation, coaching, and integration after psychedelic experiences
7Navy Seal To CIA Contractor - Shawn Ryan

Former SEAL and CIA contractor Shawn Ryan tells Chris Williamson about his experience with psychedelic-assisted therapy — ibogaine and 5-MeO-DMT — in the context of PTSD-related anger and alcohol use. Recorded in 2022, well before the executive-order news cycle, this is a personal-history reference point for how veterans were describing these treatments at the time.

Keanu Reeves’ training and what makes a good student in weapons/tacticsCritics vs. audiences, Hollywood agendas, diversity, and the rise of podcasts/YouTubeIntellectual elites, “midwits,” social media, and declining attention/critical thinkingSEAL and CIA culture: selection, training, politics, and the realities of warPsychedelic-assisted therapy (ibogaine, 5-MeO) for PTSD, anger, and alcohol use

For Huberman's own framing of ibogaine in context. In a wider conversation with Lex Fridman, Huberman discusses ayahuasca, psilocybin, and ibogaine alongside the cannabis-research controversy and his thinking on psychedelic-assisted PTSD and addiction treatment as a science communicator rather than a guest. Useful if you've already heard the long-form Huberman ibogaine episodes and want the meta view.

Career evolution, mentorship, and the eventual “exit” from podcastingPractices for creativity, focus, and accessing the unconscious mindScientific controversy, online behavior, and public trust in scienceCannabis, nicotine, peptides, GLP‑1 drugs, and broader health debatesJungian psychology: shadow, unconscious, relationships, and meaning

How we picked these

We searched every transcript in our catalog of 6,000+ podcast episodes for substantive discussion of ibogaine, then ranked by relevance — not popularity, recency, or paid placement. Summaries and topic tags are AI-generated from the full transcripts.

Related topics

Get more out of YouTube videos.

High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.

Add to Chrome